Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin Study Group.
Hiddemann W, Schmitz N, Pfreundschuh M, Pflüger KH, Ollech-Chwoyka J, Tirier C, Maschmeyer G, Kirchner H, Wagner T, Koch P, et al. Hiddemann W, et al. Among authors: koch p. Cancer. 1990 Sep 1;66(5):838-43. doi: 10.1002/1097-0142(19900901)66:5<838::aid-cncr2820660504>3.0.co;2-r. Cancer. 1990. PMID: 2386912
New aspects in the treatment of advanced low-grade non-Hodgkin's lymphomas: prednimustine/mitoxantrone versus cyclophosphamide/vincristine/prednisone followed by interferon alfa versus observation only--a preliminary update of the German Low-Grade Lymphoma Study Group.
Hiddemann W, Unterhalt M, Koch P, Nahler M, Herrmann R. Hiddemann W, et al. Among authors: koch p. Semin Hematol. 1994 Apr;31(2 Suppl 3):32-5. Semin Hematol. 1994. PMID: 8073307 Clinical Trial. No abstract available.
[The therapy of primary gastric lymphomas].
Koch P, van de Loo J. Koch P, et al. Dtsch Med Wochenschr. 1993 Nov 5;118(44):1625-6. Dtsch Med Wochenschr. 1993. PMID: 8223220 German. No abstract available.
[Diagnosis and therapy of gastrointestinal lymphoma].
Koch P, Koch OM, Herrmann R. Koch P, et al. Among authors: koch om. Internist (Berl). 1993 Feb;34(2):155-60. Internist (Berl). 1993. PMID: 8454429 Review. German. No abstract available.
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromes.
Verbeek W, Wörmann B, Koch P, Aul C, Hinrichs HF, Balleisen L, Rowe JM, Bennett J, Haase D, Fonatsch C, Heinecke A, Büchner T, Hiddemann W. Verbeek W, et al. Among authors: koch p. J Cancer Res Clin Oncol. 1999;125(6):369-74. doi: 10.1007/s004320050288. J Cancer Res Clin Oncol. 1999. PMID: 10363570 Clinical Trial.
Treatment of relapsed acute lymphocytic leukemia in adults.
Freund M, De Boben M, Diedrich H, Ganser A, Heil G, Heyll A, Henke M, Hiddemann W, Knauf U, Koch P, et al. Freund M, et al. Among authors: koch p. Haematol Blood Transfus. 1990;33:432-6. doi: 10.1007/978-3-642-74643-7_80. Haematol Blood Transfus. 1990. PMID: 2182434 Clinical Trial.
1,158 results